4-[3-(1-Naphthyl)phenyl]-2-(3-pyridylmethyl)-3-oxo-3,4-dihydropyrido[2,3-b]pyrazine | 176030-68-5

• 分子结构分类: 有机化合物
• 英文名称: 4-[3-(1-Naphthyl)phenyl]-2-(3-pyridylmethyl)-3-oxo-3,4-dihydropyrido[2,3-b]pyrazine
• 英文别名: 4-[3-(1-Naphthyl)phenyl]-2-(pyridin-3-ylmethyl)-3-oxo-3,4-dihydropyrido[2,3-b]pyrazine；4-(3-Naphthalen-1-ylphenyl)-2-(pyridin-3-ylmethyl)pyrido[2,3-b]pyrazin-3-one
• CAS: 176030-68-5
• 化学式: C₂₉H₂₀N₄O
• 分子量: 440.504
• InChiKey: QBOFMPWSDRYWGP-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  5.1
• 重原子数：
  34
• 可旋转键数：
  4
• 环数：
  6.0
• sp3杂化的碳原子比例：
  0.03
• 拓扑面积：
  58.4
• 氢给体数：
  0
• 氢受体数：
  4

文献信息

• Heterobicyclic derivatives
  申请人：FUJISAWA PHARMACEUTICAL CO., LTD.

  公开号：US20020107251A1

  公开（公告）日：2002-08-08

  Heterobicyclic derivatives of the formula: 1 wherein R 1 is aryl which may have suitable substituent(s), ar(lower)alkyl which may have suitable substituent(s), halo(lower)alkyl, protected carboxy(lower)alkyl, acyl(lower)alkyl, heterocyclic group or heterocyclic(lower)alkyl which may have suitable substituent(s), R 2 is aryl which may have suitable substituent(s) or heterocyclic group, and R 3 is hydrogen, lower alkoxy or arylthio, and a pharmaceutically acceptable salt thereof which are useful as a medicament.

  公式为1的杂环双环衍生物，其中：R1是苯基，可以具有适当的取代基；芳基（较低）烷基，可以具有适当的取代基；卤代（较低）烷基；保护的羧基（较低）烷基；酰基（较低）烷基；杂环基或者可以具有适当的取代基的杂环（较低）烷基；R2是苯基，可以具有适当的取代基或者杂环基；R3是氢、较低烷氧基或者芳基硫醚。它们的药物可接受盐是有用的。
• Pyrido[2,3-a]pyrazine derivatives as PDE-IV and TNF inhibitors
  申请人：FUJISAWA PHARMACEUTICAL CO., LTD.

  公开号：EP0920867A1

  公开（公告）日：1999-06-09

  Heterobicyclic derivatives of formula (I) wherein R1 is aryl which may have suitable substituent(s), ar(lower)alkyl which may have suitable substituent(s), halo(lower)alkyl, protected carboxy(lower)alkyl, acyl(lower)alkyl, heterocyclic group or heterocyclic(lower)alkyl which may have suitable substituent(s), R2 is aryl which may have suitable substituent(s) or heterocyclic group, and R3 is hydrogen, lower alkoxy or arylthio, and a pharmaceutically acceptable salt thereof which are useful as PDE IV and TNF inhibitors for the treatment of hepatitis in human beings and animals.

  式(I)的杂双环衍生物 其中 R1 是芳基，可具有合适的取代基；ar(低级)烷基，可具有合适的取代基；卤代(低级)烷基；受保护的羧基(低级)烷基；酰基(低级)烷基；杂环基团或杂环(低级)烷基，可具有合适的取代基、R2 是芳基（可有适当的取代基）或杂环基，R3 是氢、低级烷氧基或芳硫基，及其药学上可接受的盐，可作为 PDE IV 和 TNF 抑制剂用于治疗人类和动物的肝炎。
• HETEROBICYCLIC DERIVATIVES
  申请人：FUJISAWA PHARMACEUTICAL CO., LTD.

  公开号：EP0770079B1

  公开（公告）日：2003-02-12
• US6426345B1
  申请人：——

  公开号：US6426345B1

  公开（公告）日：2002-07-30
• US6727245B2
  申请人：——

  公开号：US6727245B2

  公开（公告）日：2004-04-27